NeuroTrauma Sciences Employee Directory

NeuroTrauma Sciences corporate office is located in 2655 Northwinds Pkwy Ste 5C, Alpharetta, Georgia, 30009, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Operations

4

Finance

2

Engineering & Technical

2

C-Suite

1

NeuroTrauma Sciences CEO

CL
United States flag for contact location.
Carl LongChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of NeuroTrauma Sciences

  • MD
    United States flag for contact location.
    Marc De

    Chief Medical Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

NeuroTrauma Sciences Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from NeuroTrauma Sciences

Hundreds of professionals searching for NeuroTrauma Sciences have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at NeuroTrauma Sciences

Explore people who held key positions, contributed to NeuroTrauma Sciences's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Georgia, United States

Frequently Asked Questions Regarding NeuroTrauma Sciences Employees

How many employees does NeuroTrauma Sciences have?
NeuroTrauma Sciences has 11-50 employees
Who is the CEO of NeuroTrauma Sciences?
NeuroTrauma Sciences’s CEO is Carl Long
Who are NeuroTrauma Sciences key employees?
Some of NeuroTrauma Sciences key employees are Marc De
Where is NeuroTrauma Sciences located?
NeuroTrauma Sciences’s headquarters are located at 2655 Northwinds Pkwy Ste 5C, Alpharetta, Georgia, 30009, United States
How do I contact NeuroTrauma Sciences?
NeuroTrauma Sciences Contact Info: Phone number: (833) 278-2888 Website: www.neurotraumasciences.com
What does NeuroTrauma Sciences do?

NeuroTrauma Sciences (NTS) is a clinical stage biopharmaceutical company established in 2016, dedicated to enhancing the treatment of stroke patients, specifically focusing on acute ischemic stroke and chronic stroke. The company is currently advancing its lead compound, NTS-104, through Phase 1 clinical trials, expected to complete in 2025. NTS is... led by a team of experienced professionals in neuroscience and drug development, aiming to innovate in the field of neuroprotection. Their target clients include healthcare providers and patients affected by stroke, as well as potential partners in the pharmaceutical industry.Read More

Is NeuroTrauma Sciences a public company?
NeuroTrauma Sciences is private company therefore does not currently have an official ticker symbol
See more information about NeuroTrauma Sciences Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.